Petroreconcavo (RECV3) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
18 Jun, 2026Reserve certification and growth
2P reserves for 2025 certified at 182.2 MMBOE, supporting 19 years of production at current pace.
Reserve Replacement Ratio (RRR) maintained at 1.0x, indicating full replacement of produced reserves.
Future reserves development cost estimated at US $8.4/boe, with PV10 value of US $2.4 billion.
43% of total 2P reserves are gas, highlighting a balanced portfolio.
Recovery factors for oil and gas show potential for further expansion, benchmarking favorably against industry standards.
Production and cash flow outlook
WI production projected to remain stable, ranging from 26 to 37 kboe/day through 2035.
Operating cash flow expected to be robust, with a growth trajectory supported by consistent production.
Lower Brent price curve and increased lifting costs partially offset by reduced midstream costs.
Operating cash flow after CAPEX remains strong, with PV10 at US $2.4 billion for 2025.
Certification highlights operational resilience and adaptability to market changes.
Capital expenditure and cost management
2P development CAPEX for the next five years averages around US $130 million annually.
2P reserve development cost remains stable at approximately US $8.4/boe.
Short-term CAPEX reduction achieved through exchange rate gains and project optimization.
Expansion of secondary recovery projects supports long-term reserve growth.
CAPEX allocation is closely aligned with operating cash flow to ensure financial discipline.
Latest events from Petroreconcavo
- Strong financials, robust reserves, and disciplined growth drive sustainable returns.RECV3
Investor presentation12 Jun 2026 - Cost discipline and CapEx cuts drove margin gains and a 492% jump in free cash flow.RECV3
Q1 202622 May 2026 - Net income rose 46% in 2025, with R$ 3.2 billion revenue and 65% of 2026 oil hedged.RECV3
Q4 202525 Apr 2026 - Record revenue, EBITDA, and cash flow growth with stable production and major investments.RECV3
Q2 20242 Feb 2026 - Net revenue and income rose, with robust dividends and new projects driving future growth.RECV3
Q3 202415 Jan 2026 - Record EBITDA and net revenue, with robust cash flow and high dividend payout in 2024.RECV3
Q4 202427 Dec 2025 - Net income rose 5% as production held steady and strategic investments accelerated.RECV3
Q2 202523 Nov 2025 - Net revenue and EBITDA up sharply, with strong cash flow, lower leverage, and 50% hedged.RECV3
Q1 202520 Nov 2025 - Sequential declines in revenue and EBITDA offset by strategic investments and asset acquisitions.RECV3
Q3 202513 Nov 2025